DNASE1L3 Mutations in Hypocomplementemic Urticarial Vasculitis Syndrome

Overview of attention for article published in Arthritis and rheumatism, July 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 1 X user
patent: 13 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 84 Mendeley

So far, Altmetric has seen 13 patents that reference this research output.

Engineered DNASE enzymes for thrombosis therapy

Grant US-12565642-B2

United States of America

03 Mar 2026

MODIFIED RNA FOR THE TREATMENT OF CFDNA-ASSOCIATED DISEASES

Application WO-2025176838-A1

World Intellectual Property Organisation (WIPO)

28 Aug 2025

MODIFIED RNA FOR THE TREATMENT OF CFDNA-ASSOCIATED DISEASES

Application EP-4606900-A1

European Patent Office

27 Aug 2025

CELL-FREE DNA FRAGMENTATION AND NUCLEASES

Application EP-4524971-A2

European Patent Office

19 Mar 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 9 additional patents.